The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

Robert F. Kennedy Jr is known as a persistent critic of vaccine safety and is a longtime antagonist of the Food and Drug ...

Former President Donald Trump has boasted in recent months about "Right to Try," a law he signed in 2018. It’s aimed at boosting terminally ill patients’ access to potentially life-saving medications ...

BERLIN--(BUSINESS WIRE)--Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for the investigational compound ...

Three states have picked up a lawsuit previously dismissed by the U.S. Supreme Court earlier this year against the Food and Drug Administration (FDA) over its removal of safety restrictions on ...

From family planning to hospital bills, the new Trump administration has the potential to affect a wide range of policies in ...

today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL), dated October 22, 2024, for the ketamine Abbreviated New Drug Application, which was ...

to the U.S. Food and Drug Administration (FDA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran is ...

The records covered the period January 2014—which, as the study notes, “coincided with the initial US Food and Drug Administration approval of many GLP-1 RA medications”—to September 2022.